Trikafta (elexacaftor/tezacaftor/ivacaftor; ivacaftor)

Trikafta (elexacaftor/tezacaftor/ivacaftor; ivacaftor) is a medication used for the treatment of cystic fibrosis (CF), indicated for CF patients aged 12 years and older with certain mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that are responsive to Trikafta based on in vitro data.